Filing Details
- Accession Number:
- 0001209191-19-035661
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-06-07 19:16:03
- Reporting Period:
- 2019-06-05
- Accepted Time:
- 2019-06-07 19:16:03
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
921299 | Fibrogen Inc | FGEN | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1621333 | Kalevi Kurkijarvi | C/O Fibrogen, Inc. 409 Illinois St. San Francisco CA 94158 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2019-06-05 | 4,700 | $0.00 | 28,400 | No | 4 | A | Direct | |
Common Stock | Acquisiton | 2019-06-06 | 6,000 | $2.90 | 34,400 | No | 4 | M | Direct | |
Common Stock | Disposition | 2019-06-06 | 2,942 | $37.20 | 31,458 | No | 4 | S | Direct | |
Common Stock | Disposition | 2019-06-06 | 3,058 | $38.49 | 28,400 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | A | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Acquisiton | 2019-06-05 | 7,800 | $0.00 | 7,800 | $39.03 |
Common Stock | Stock Option (Right to Buy) | Disposition | 2019-06-06 | 6,000 | $0.00 | 6,000 | $2.90 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
7,800 | 2029-06-05 | No | 4 | A | Direct | |
0 | 2020-06-24 | No | 4 | M | Direct |
Footnotes
- Represents the grant of restricted stock units that vest on the earlier of June 5, 2020 or the date of the next annual meeting of stockholders.
- Shares sold pursuant to a 10b5-1 plan.
- The shares were sold at prices ranging from $37.12 to $38.02. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The shares were sold at prices ranging from $38.18 to $39.01. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- Options vest on the earlier of June 5, 2020 or the date of the next annual meeting of stockholders.
- Fully vested.